Redefining Cancer Care for Children With Blinatumomab
A groundbreaking cancer drug, Blina, brings relief to children like Arthur, offering effective treatment with minimal side effects.
Stay updated with breaking news from Improves Survival. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A groundbreaking cancer drug, Blina, brings relief to children like Arthur, offering effective treatment with minimal side effects.
CALQUENCE six-year follow-up data reinforce long-term benefit in chronic lymphocytic leukemia, and data across multiple hematology assets showcase breadth of promising early pipeline New,...
Leukine is FDA Approved to Treat Acute Radiation Syndrome (ARS) and Recommended in EMEA/CPMP Guidance to Treat Systemic Sulfur Mustard (HD) Gas Exposure Tanner Pharma Group, an international distributor
Tanner Pharma Group, an international distributor of essential medicines, announced that it has significantly increased its inventory of Leukine ...
Partner Therapeutics Announces Publication of Two Studies Demonstrating Leukine® Improves Survival in Acute Radiation Syndrome (ARS) - Studies Showed Statistically Significant Improvements in Survival in Subjects Treated with Leukine Starting 48 Hours After Acute, High Dose Radiation Exposure without Need for Blood Transfusions or Other Forms of Intensive Supportive Care - Leukine Administration Starting 48, 72, 96 and 120 Hours after Lethal Radiation Exposure: - Enhanced Recovery of Platelets, Lymphocytes, Neutrophils and Reticulocytes - Reduced Frequency, Severity and Duration of Infection...